MetaCap

Immuneering Statistics

NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.38-0.07 (-2.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Immuneering by the numbers

Immuneering has a market capitalization of $218.9 million based on 64.76M shares outstanding. With trailing EPS of $-0.92, Immuneering is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.9% below its 50-day average and 28.3% below its 200-day average.

Average daily trading volume is 747.66K shares, or about $2.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IMRX valuation vs. peer median

IMRX compared with the median of 8 peer companies
MetricIMRXPeer medianDifference
Market cap$218.90M$215.61M+2%
Avg. volume747.66K954.92K-22%

Peer median across 8 companies: RCKT, KROS, PYXS, ENTA, ARCT, CYPH, VNDA, FTH.

Valuation

Price and trading

Previous close
3.45
Open
3.38
Day range
3.29 – 3.54
52-week range
3.29 – 8.48
52-week change
-53.70%
Beta
—
Volume
1.45M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
218.90M
Forward Pe
-2.06
Eps
-0.92
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
8.48
Week52 Low
3.29
Avg Volume
747.66K
Shares Outstanding
64.76M
Ma50
3.88
Ma200
4.71
Earnings Date
Oct 29, 2026
Pct From52w High
-60.14%
Pct From52w Low
2.77%

Related